1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends

Diagnostics and Therapeutics for Lung Cancer: Global Markets

  • May 2015
  • 178 pages
  • BCC Research
Report ID: 3007880

Summary

Table of Contents

This BCC Research report analyzes the market for diagnostics and therapeutics for lung cancer, and also focuses on regulations and reimbursements affecting diagnostics tests and drugs used in therapeutics.

Use this report to:
- Analyze market revenues of the global lung cancer market segments and subsegments based on geographies and products.
- Identify regulations and government supported programs impacting the lung cancer market.
- Learn about various lung cancer diagnostics tests and lung cancer therapeutics like chemotherapy, radiotherapy and surgery.

Highlights
- The global market for lung cancer grew to $21.9 billion in 2014 from $20.3 billion in 2013. The market is expected to grow at a five-year compound annual growth rate (CAGR) of 7.8% from 2014 to 2019, totaling $31.8 billion in 2019.
- The Asia-Pacific market totaled nearly $7 billion in 2013. This market is estimated to grow from $7.5 billion in 2014 to nearly $11.3 billion by 2019 at a CAGR of 8.5%.
- The European market for lung cancer totaled $6.1 billion in 2013. This market is expected to grow from $6.6 billion in 2014 to $9.5 billion by 2019 at a CAGR of 7.6%.

Introduction & Scope

INTRODUCTION
This report discusses the global lung cancer market in terms of growth, size and opportunities. The report analyzes the market for diagnostics and therapeutics for lung
cancer, and also focuses on regulations and reimbursements affecting diagnostics tests and drugs used in therapeutics. Regionally, the study focuses on North America,
Europe, Asia-Pacific and Rest of the World.

STUDY AND OBJECTIVES
- Define and discuss the global lung cancer market.
- Analyze market structure by segments and subsegments.
- Estimate market revenues of the global lung cancer market segments and subsegments by geographies and products.
- Identify market trends, issues and factors impacting lung cancer market.
- Explain opportunities in the lung cancer market with respect to geography, diagnostics and therapeutics.
- Profile major players and analyze their core competencies and strategies for the lung cancer market.
- Track alliances, joint ventures, mergers and acquisitions, new product developments, and research and development in the global lung cancer market.

TITLE DESCRIPTION
Lung cancer is the number one cancer that has fatally affected the most people in the U.S., and is more prevalent than breast, prostate and colon cancers. The survival rate
of lung cancer is extremely low; an efficient, early-stage diagnostic test has still not been identified. Tobacco smoke is the prime reason for developing lung cancer. There
are two types of lung cancer: small cell lung cancer (SCLC), which is around 15%; and non-small cell lung cancer (NSCLC), which is 85% of the total lung cancers. SCLC
cannot be operated upon, and hence the survival rate is low. NSCLC is the more common of the two types of lung cancer, and its growth is slower compared to the
SCLC. It is of three types as per the cell structure: squamous cell carcinoma, adenocarcinoma and the large cell carcinoma.

SCOPE OF THE REPORT
The report will analyze the lung cancer market as per diagnostics and therapeutics, and will also focus on the regulations and government supported programs impacting
this market. Regionally, the focus of study will be the markets of North America, Europe, Asia-Pacific and Rest of the World (ROW). This report includes various lung cancer diagnostics tests like histology/cytology, immunoassays, flow cytometry, rapid tests, molecular assays, tissue arrays, circulating tumor cells, pharmacodiagnostics, and molecular biomarkers, etc. Lung cancer therapeutics include chemotherapy, radiotherapy and surgery.

MARKET STRUCTURE
The global lung cancer markets analyzed in the report include the competitive landscape and profiles of key players of the lung cancer market as well as regional and
product analysis. The global lung cancer market is also broken down by the diagnostics and therapeutics market.

INTENDED AUDIENCE
- Equipment distributors, hospitals and other healthcare service providers.
- Life sciences companies and diagnostic laboratories.
- Research institutes, associations and academicians.

RESEARCH METHODOLOGY
A top-down approach was taken to estimate the size of the lung cancer market. To calculate market sizes, the following details were taken into account:
- Revenues of the lung cancer market are determined through primary and secondary research, including a study of the annual reports of listed market players.
- Secondary research includes a general search by keywords through paid sources such as Factiva as well as other publicly available websites and company websites.
- Micro markets are estimated through primary and secondary sources, and validated through primary sources.
- Forecasts are based on the analysis of market trends, market dynamics and strategies of key companies.
- Geographic estimates are derived from secondary sources verified through primary sources.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Ahmad helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Cutaneous Squamous cell Carcinoma- Competitive Landscape, Market Insights, Epidemiology and Market Forecast-2025

  • $ 6950
  • Industry report
  • July 2017
  • by Delve Insight

DelveInsight’s ‘Cutaneous Squamous Cell Carcinoma (cSCC) - Competitive Landscape, Market Insights, Epidemiology and Market Forecast-2025’ report provides provides the comprehensive insights on the ...

Cutaneous Squamous cell Carcinoma (CsCC) - Market Insights, Epidemiology and Market Forecast – 2025

  • $ 5750
  • Industry report
  • July 2017
  • by Delve Insight

DelveInsight’s “Cutaneous Squamous cell Carcinoma (CsCC) - Market Insights, Epidemiology and Market Forecast – 2025” Reports provides an overview of the disease and global market size of the Cutaneous ...

Potential "Pipeline Disruptors" - New Products That Will Drive The Future Pharmaceutical Market

  • $ 4200
  • Industry report
  • May 2017
  • by Kalorama Information

Potential Pipeline Disruptors: Innovative Pharmaceuticals in Alzheimer's Disease, Asthma and Cancer This report covers market opportunities based on pipeline developments for six key therapeutic specialities: ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.